Answer to the CDC: Validation Must Precede Promotion
Abstract
We would like to thank the CDC colleagues for their Commentary in what constitutes the first comment on a paper published in the Annals in decades. We view critique as a strength of scientific exploration. The Commentary concludes with as statement agreeing with the findings and conclusions of our paper: “we recognize CDC SVI may not identify the most vulnerable populations in all applications and has not done so in the Rufat et al. study (…) we agree with the authors.”
Fichier principal
AAG_2021_Answer_to_the_CDC_Validation_Must_Precede_Promotion.pdf (269.12 Ko)
Télécharger le fichier
Origin : Files produced by the author(s)